In his feature with CEOViews, Dr. Nathan S. Bryan, Founder and CEO of Bryan Therapeutics, shared how his company is transforming cardiovascular and chronic disease treatment through nitric oxide science.
Dr. Bryan explained that nitric oxide is essential for maintaining cardiovascular health because it regulates blood flow, supports endothelial function, and prevents inflammation. Loss of nitric oxide production, he said, is one of the earliest signs of chronic disease, including heart disease, Alzheimer’s, and diabetes.
Bryan Therapeutics is leading innovation with both pharmaceutical and consumer product lines. Its N1O1 lozenges and NO Beetz fermented beet powder safely generate nitric oxide in the body, improving circulation, energy, and cellular function. The company’s topical skincare line also utilizes nitric oxide to boost collagen, hydration, and skin regeneration.
Dr. Bryan emphasized that restoring nitric oxide production can address the root cause of many diseases, improving health from within. With decades of research and numerous patents, Bryan Therapeutics continues to set new standards for nitric oxide delivery and therapeutic applications.